Skip to main content

Table 2 Demographic characterization of the cohort used in the preliminary validation

From: A different vision of translational research in biomarker discovery: a pilot study on circulatory mitochondrial proteins as Parkinson’s disease potential biomarkers

 Age at blood coll. (y)aGenderb
Parkinson’s Disease Group60.1 ± 10.7 [38, 79]M: 9 (40.9%); F: 13 (59.1%)
Control Group67.5 ± 7.2 [53, 75]M: 3 (25%); F: 9 (75%)
  1. aAge at blood coll. (y): age at blood collection in years
  2. bThe individuals were divided into males (M) and females (F)